Genmab — Marts 2019
-
GSK2857916 anti-BCMA in Nature https://www.nature.com/articles/s41408-019-0196-6
-
@bibob 14.36 hehehe du får det til at lyde som om AB er en storaktionær der kan styre genmabs kurs op eller ned efter behag. Faktum er at AB = markedet og markedet består af tusindvis af handlende men der kan selvfølgelig være noglre mega store aktøre blandt de tusindvis af handlende som kan påvirke kursen i en hvis grad.
-
-
But they are unsure why it seems that pts benefit better if no prior dara-treatment. Could be that pts are more ill. And notable: "Future studies may also investigate the use of GSK2857916 as a key component for combination with other therapies and in other MM populations."
-
No..no.. jeg er kun en lille ydmyg aktionær..:-D
-
Maria må godt snart komme i hus https://www.youtube.com/watch?v=jvYagLTa_GY
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind